Yet , time-to-relapse was longer in FHP placebo responders ( n = 8 ) compared to FHN placebo responders ( n = 9 ) with , again , no significant difference in time-to-relapse in FHP riluzole responders ( n = 6 ) compared to FHN riluzole responders ( n = 9 ) .